Recent Insider Activity Suggests Potential Gains for Phathom Pharmaceuticals Inc (PHAT)
Phathom Pharmaceuticals Inc’s recent filing unveils that its CFO and CBO Henderson Molly unloaded Company’s shares for reported $38128.0 on Apr 08 ’24. In the deal valued at $11.10 per share,3,435 shares were sold. As a result of this transaction, Henderson Molly now holds 95,263 shares worth roughly $0.85 million. Then, Curran Terrie sold 16,851 […]
Keeping an Eye on Phathom Pharmaceuticals Inc (PHAT) After Insider Trading Activity
Phathom Pharmaceuticals Inc’s recently made public that its CFO and CBO Henderson Molly unloaded Company’s shares for reported $38128.0 on Apr 08 ’24. In the deal valued at $11.10 per share,3,435 shares were sold. As a result of this transaction, Henderson Molly now holds 95,263 shares worth roughly $0.95 million. Then, Curran Terrie sold 16,851 […]
PHAT’s short interest shows a sharp rise on Mar 15, 2024
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Phathom Pharmaceuticals Inc shares valued at $38,128 were sold by Henderson Molly on Apr 08 ’24. At $11.10 per share, Henderson Molly sold 3,435 shares. The insider’s holdings dropped to 95,263 […]
Phathom Pharmaceuticals Inc [PHAT] Insider Curran Terrie sells 16,851 Shares – Latest News
Phathom Pharmaceuticals Inc’s recently made public that its President and Chief Executive Curran Terrie unloaded Company’s shares for reported $0.15 million on Mar 22 ’24. In the deal valued at $9.11 per share,16,851 shares were sold. As a result of this transaction, Curran Terrie now holds 410,784 shares worth roughly $4.56 million. Then, TAKEDA PHARMACEUTICAL […]
Phathom Pharmaceuticals Inc [PHAT] stock for 153,513 USD was sold by Curran Terrie
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Phathom Pharmaceuticals Inc shares valued at $153,513 were sold by Curran Terrie on Mar 22 ’24. At $9.11 per share, Curran Terrie sold 16,851 shares. The insider’s holdings dropped to 410,784 shares worth approximately […]
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently
In a filing, Phathom Pharmaceuticals Inc revealed its President and Chief Executive Curran Terrie unloaded Company’s shares for reported $0.15 million on Mar 22 ’24. In the deal valued at $9.11 per share,16,851 shares were sold. As a result of this transaction, Curran Terrie now holds 410,784 shares worth roughly $4.36 million. Then, TAKEDA PHARMACEUTICAL […]
Negative sentiment towards PHAT reflected by a jump of 0.46% in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Phathom Pharmaceuticals Inc shares valued at $153,513 were sold by Curran Terrie on Mar 22 ’24. At $9.11 per share, Curran Terrie sold 16,851 shares. The insider’s holdings dropped to 410,784 shares worth approximately […]
The Attractiveness of Investing In Phathom Pharmaceuticals Inc (PHAT) is Growing
Phathom Pharmaceuticals Inc’s recent filing unveils that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s shares for reported $30.0 million on Jan 24 ’24. In the deal valued at $8.10 per share,3,703,703 shares were sold. As a result of this transaction, TAKEDA PHARMACEUTICAL CO LTD now holds 3,755,583 shares worth roughly $41.39 million. Then, […]
